-
Hovland and Gerard share lead at Tour Championship
-
Kane confirms talks on Bayern extension
-
Maresca salutes 'unbelievable' Cherki after Man City star sinks Palace
-
Trump govt. mulls deal to give away part of Yosemite park
-
Marquinhos rescues last-gasp draw for PSG at Lille in Ligue 1
-
Indian release of Sonia Gandhi memoir uncertain after publisher clarification
-
ICE detains British far-right activist Milo Yiannopoulos in Louisiana
-
Cities show cleaner transport policies can reduce severe air pollution
-
Milo Yiannopoulos held by ICE after missing immigration hearing
-
Four patients harmed in Nashville hospital medication mix-up
-
Six Flags closes X2 rollercoaster after reports of severe brain injuries
-
Essex council hires private guards as Wethersfield asylum centre expands
-
Jury ends second day without verdict in Lindsay Clancy murder trial
-
Haakon VIII becomes Norway's king after Harald V dies at 89
-
Artist says criticised Ronnie O'Sullivan mural is unfinished
-
Six injured after sign falls at Christian festival in West Sussex
-
UAE grants Starlink 10-year satellite broadband licence
-
Dubai airport expands scanners that keep laptops and liquids in bags
-
US says Hormuz mines cleared as diplomacy and military deployments continue
-
Kuwait and Pakistan sign military cooperation agreement
-
Nepal-Tibet flood toll reaches 584 as more than 2,400 remain missing
-
Ramos strikes as AC Milan beat Venezia
-
Cherki makes his point to Maresca as Man City sparkle in Palace rout
-
COP17 soil assessment links worsening land degradation to food and nutrition risks
-
Odisha faces very heavy rain as Sri Ganganagar reaches 41.4C
-
Scammers in China exploit Microsoft Teams and other workplace apps to target victims
-
GSA employees report mice, ceiling damage and cloudy water after Washington office move
-
Medical AI paper predicts autonomous systems could outperform doctors in core clinical tasks by 2030
-
REI Labor Day sale runs through September 7 with outdoor gear discounts
-
Cara and former scraper develop open-source tool to alert artists when work appears in AI datasets
-
Meta tests robots for cabling, server resets and maintenance inside data centers
-
Google expands easier file sharing between Android phones and Apple devices
-
Nepal-Tibet flood rescue resumes after overflowing debris lake forces temporary withdrawal
-
UK chefs turn to induction cooking to reduce kitchen heat, energy use and pollution
-
Extreme heat exposes vulnerabilities across Britain's rail network
-
Restored Cheshire wetland becomes key UK breeding site for black-necked grebes
-
Dollar rallies after Fed chief lifts rate expectations
-
Bayern steamroll Stuttgart in Bundesliga opener
-
Slumping Sabalenka 'confident' ahead of US Open three-peat bid
-
England pace quartet might keep Archer going until he is 40
-
Aston Villa seal swoop for Chelsea striker Jackson
-
Driven by distraction? Trump steps up stunts as US midterms loom
-
Number of missing in deadly Nepal, China floods jumps past 2,400
-
Springboks a wounded beast, warns All Blacks captain Savea
-
Birmingham City Seek First Championship Win Against Wrexham
-
Trump announces new US 'Space Academy'
-
Four-wicket Robinson stars as Pakistan collapse in second Test
-
Best Laser Printers in India: Top Options from HP, Brother and Canon
-
Alcaraz anxious after layoff but feels 'great' about wrist
-
US Monroe Doctrine Revival Risks Pushing Latin America Toward China
California start-up sends tiny robots on voyage into brains
Sending miniature robots deep inside the human skull to treat brain disorders has long been the stuff of science fiction -- but it could soon become reality, according to a California start-up.
Bionaut Labs plans its first clinical trials on humans in just two years for its tiny injectable robots, which can be carefully guided through the brain using magnets.
"The idea of the micro robot came about way before I was born," said co-founder and CEO Michael Shpigelmacher.
"One of the most famous examples is a book by Isaac Asimov and a film called 'Fantastic Voyage,' where a crew of scientists goes inside a miniaturized spaceship into the brain, to treat a blood clot."
Just as cellphones now contain extremely powerful components that are smaller than a grain of rice, the tech behind micro-robots "that used to be science fiction in the 1950s and 60s" is now "science fact," said Shpigelmacher.
"We want to take that old idea and turn it into reality," the 53-year-old scientist told AFP during a tour of his company's Los Angeles research and development center.
Working with Germany's prestigious Max Planck research institutes, Bionaut Labs settled on using magnetic energy to propel the robots -- rather than optical or ultrasonic techniques -- because it does not harm the human body.
Magnetic coils placed outside the patient's skull are linked up to a computer that can remotely and delicately maneuver the micro-robot into the affected part of the brain, before removing it via the same route.
The entire apparatus is easily transportable, unlike an MRI, and uses 10 to 100 times less electricity.
- 'You're stuck' -
In a simulation watched by AFP, the robot -- a metal cylinder just a few millimeters long, in the shape of a tiny bullet -- slowly follows a pre-programed trajectory through a gel-filled container, which emulates the density of the human brain.
Once it nears a pouch filled with blue liquid, the robot is swiftly propelled like a rocket and pierces the sack with its pointed end, allowing liquid to flow out.
Inventors hope to use the robot to pierce fluid-filled cysts within the brain when clinical trials begin in two years.
If successful, the process could be used to treat Dandy-Walker Syndrome, a rare brain malformation affecting children.
Sufferers of the congenital ailment can experience cysts the size of a golf ball, which swell and increase pressure on the brain, triggering a host of dangerous neurological conditions.
Bionaut Labs has already tested its robots on large animals such as sheep and pigs, and "the data shows that the technology is safe for us" human beings, said Shpigelmacher.
If approved, the robots could offer key advantages over existing treatments for brain disorders.
"Today, most brain surgery and brain intervention is limited to straight lines -- if you don't have a straight line to the target, you're stuck, you're not going to get there," said Shpigelmacher.
Micro-robotic tech "allows you to reach targets you were not able to reach, and reaching them repeatedly in the safest trajectory possible," he added.
- 'Heating up' -
The US Food and Drug Administration (FDA) last year granted Bionaut Labs approvals that pave the way for clinical trials to treat Dandy-Walker Syndrome, as well as malignant gliomas -- cancerous brain tumors often considered to be inoperable.
In the latter case, the micro-robots will be used to inject anti-cancer drugs directly into brain tumors in a "surgical strike."
Existing treatment methods involve bombarding the whole body with drugs, leading to potential severe side effects and loss of effectiveness, said Shpigelmacher.
The micro-robots can also take measurements and collect tissue samples while inside the brain.
Bionaut Labs -- which has around 30 employees -- has held discussions with partners for the use of its tech to treat other conditions affecting the brain including Parkinson's, epilepsy or strokes.
"To the best of my knowledge, we are the first commercial effort" to design a product of this type with "a clear path to the clinic trials," said Shpigelmacher.
"But I don't think that we will be the only one... This area is heating up."
P.AbuBaker--SF-PST